199 related articles for article (PubMed ID: 17509532)
1. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.
Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC
Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563
[TBL] [Abstract][Full Text] [Related]
3. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
Frecer V; Megnassan E; Miertus S
Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.
Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC
Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916
[TBL] [Abstract][Full Text] [Related]
5. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
Kumar SP; George LB; Jasrai YT; Pandya HA
SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
[TBL] [Abstract][Full Text] [Related]
7. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
Shah P; Siddiqi MI
SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
[TBL] [Abstract][Full Text] [Related]
10. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
[TBL] [Abstract][Full Text] [Related]
11. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
Muench SP; Prigge ST; McLeod R; Rafferty JB; Kirisits MJ; Roberts CW; Mui EJ; Rice DW
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):328-38. PubMed ID: 17327670
[TBL] [Abstract][Full Text] [Related]
12. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
Sharma SK; Parasuraman P; Kumar G; Surolia N; Surolia A
J Med Chem; 2007 Feb; 50(4):765-75. PubMed ID: 17263522
[TBL] [Abstract][Full Text] [Related]
13. Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
Tallorin LC; Durrant JD; Nguyen QG; McCammon JA; Burkart MD
Bioorg Med Chem; 2014 Nov; 22(21):6053-6061. PubMed ID: 25284249
[TBL] [Abstract][Full Text] [Related]
14. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.
Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K
IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440
[TBL] [Abstract][Full Text] [Related]
15. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
Lindert S; Tallorin L; Nguyen QG; Burkart MD; McCammon JA
J Comput Aided Mol Des; 2015 Jan; 29(1):79-87. PubMed ID: 25344312
[TBL] [Abstract][Full Text] [Related]
16. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Neves BJ; Bueno RV; Braga RC; Andrade CH
Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
[TBL] [Abstract][Full Text] [Related]
17. SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
Kumar G; Banerjee T; Kapoor N; Surolia N; Surolia A
IUBMB Life; 2010 Mar; 62(3):204-13. PubMed ID: 20131353
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
Banerjee T; Sharma SK; Surolia N; Surolia A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
Suguna K; Surolia A; Surolia N
Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
Belluti F; Perozzo R; Lauciello L; Colizzi F; Kostrewa D; Bisi A; Gobbi S; Rampa A; Bolognesi ML; Recanatini M; Brun R; Scapozza L; Cavalli A
J Med Chem; 2013 Oct; 56(19):7516-26. PubMed ID: 24063369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
